Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 1.2.2021 | EN | Official Journal of the European Union | C 35/57 |

---

Action brought on 4 December 2020 — Degode v EUIPO — Leo Pharma (Skinovea)

(Case T-715/20)

(2021/C 35/76)

Language of the case: English

Parties

Applicant: DEGODE — Dermago Development GmbH (Petershagen, Germany) (represented by: O. Spieker, A. Schönfleisch and N. Willich, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Leo Pharma A/S (Ballerup, Denmark)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for European Union word mark Skinovea — Application for registration No 17 898 565

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 4 September 2020 in Case R 337/2020-5

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order the defendant to bear the costs of the proceedings. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)